Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease

Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease

Abstract Background Data on changes in lung function in eosinophilic chronic obstructive pulmonary disease (COPD) are limited. We investigated the longitudinal changes in forced expiratory volume in 1 s (FEV1) and effects of inhaled corticosteroid (ICS) in Korean COPD patients. Methods Stable COPD p...

Full description

Bibliographic Details
Main Authors:	Yong Suk Jo, Ji-Yong Moon, Yong Bum Park, Yee Hyung Kim, Soo-Jung Um, Woo Jin Kim, Hyoung Kyu Yoon, Kwang Ha Yoo, Ki-Suck Jung, Chin Kook Rhee
Format:	Article
Language:	English
Published:	BMC 2022-03-01
Series:	BMC Pulmonary Medicine
Subjects:	COPD Blood eosinophil count Exacerbation Forced expiratory volume in 1 s Longitudinal change
Online Access:	https://doi.org/10.1186/s12890-022-01873-8

Similar Items

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
by: Kwok WC, et al.
Published: (2023-06-01)

Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease
by: Yong Suk Jo, et al.
Published: (2022-08-01)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
by: Mkorombindo T, et al.
Published: (2019-08-01)

Comparison of Hematological Phenotypes of COPD Exacerbations in Hospitalized Patients after Emergency Department Admission
by: Emre Şancı, et al.
Published: (2023-05-01)

Relationship between Peripheral Blood Eosinophil Count and Neutrophil/Lymphocyte Ratio with Number of Attacks Leading to Hospital Admission in Chronic Obstructive Pulmonary Disease
by: Maryam Mirzaee, et al.
Published: (2020-12-01)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
by: Claus F. Vogelmeier, et al.
Published: (2019-08-01)

Blood eosinophil variability in patients presenting with acute exacerbations of COPD within the past year and its correlation with treatment plan
by: Samir Mohamed Mahmoud Fahyim, et al.
Published: (2024-03-01)

Longitudinal change of FEV1 and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD
by: Jo YS, et al.
Published: (2019-02-01)

Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation
by: Tzu-Tao Chen, et al.
Published: (2023-12-01)

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD
by: Zysman M, et al.
Published: (2017-06-01)

Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts
by: Müllerová H, et al.
Published: (2019-03-01)

Burden of disease associated with a COPD eosinophilic phenotype
by: Ortega H, et al.
Published: (2018-08-01)

COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
by: Osman Savran, et al.
Published: (2021-02-01)

Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths
by: Li Q, et al.
Published: (2019-01-01)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
by: Vestbo J, et al.
Published: (2019-04-01)

Correlation between FEV1% Predicted and Blood Eosinophils in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
by: Alfian Nurfaizi, et al.
Published: (2021-05-01)

The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world
by: Barnes N, et al.
Published: (2018-02-01)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
by: Greulich T, et al.
Published: (2018-09-01)

Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients
by: Laura Millares, et al.
Published: (2019-06-01)

Regional expiratory time constants in severe respiratory failure estimated by electrical impedance tomography: a feasibility study
by: Christian Karagiannidis, et al.
Published: (2018-09-01)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
by: Sun Hye Shin, et al.
Published: (2022-05-01)

Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis
by: Mona Bafadhel, et al.
Published: (2020-01-01)

Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study
by: So Rae Kim, et al.
Published: (2023-05-01)

Sputum cell counts to manage prednisone-dependent asthma: effects on FEV1 and eosinophilic exacerbations
by: Afia Aziz-Ur-Rehman, et al.
Published: (2017-04-01)

Exacerbation and Cardiovascular Events in Eosinophilic Chronic Obstructive Pulmonary Disease
by: Mami Orimo, et al.
Published: (2023-04-01)

Is Blood Eosinophil Count a Biomarker for Chronic Obstructive Pulmonary Disease in a Real-World Clinical Setting? Predictive Property and Longitudinal Stability in Japanese Patients
by: Koichi Nishimura, et al.
Published: (2021-02-01)

Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study
by: Fukuchi Y, et al.
Published: (2016-04-01)

Can eosinophilia and neutrophil–lymphocyte ratio predict hospitalization in asthma exacerbation?
by: Hossein Esmaeilzadeh, et al.
Published: (2021-02-01)

Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
by: Ankan Bandyopadhyay, et al.
Published: (2013-01-01)

Clinical characteristics of COPD patients with tidal expiratory flow limitation
by: Dean J, et al.
Published: (2017-05-01)

A Study of Correlation between Asthma Control Test and Lung Function Parameters
by: Rowhit Yanamadala, et al.
Published: (2021-02-01)

Variability of blood eosinophil count and prognosis of COPD exacerbations
by: Sandra Martínez-Gestoso, et al.
Published: (2021-01-01)

Are blood eosinophils a prime-time biomarker for COPD management decisions?
by: Tsiligianni I, et al.
Published: (2018-06-01)

Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”)
by: Jeremy Charriot, et al.
Published: (2023-03-01)

Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
by: Miravitlles M, et al.
Published: (2022-07-01)

Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients
by: Park HY, et al.
Published: (2015-12-01)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
by: Steven W. Yancey, et al.
Published: (2019-09-01)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
by: Song JH, et al.
Published: (2017-08-01)

Blood and sputum eosinophilia in COPD exacerbation
by: Laila Ashour Helala, et al.
Published: (2022-09-01)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
by: James Camp, et al.
Published: (2018-09-01)